-
01:28:04 AM

ABMD Stock News

12/21/22 9:00 AM
Nasdaq : ABMD
clinical trialfda approval
FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial
Abiomed announces the United States Food and Drug Administration has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients have been enrolled in the trial. Amir Kaki, MD, director of mechanical circulatory support at Ascension St. John Hospital in Detroit, led the procedures. This single-arm,...
RHEA-AI
neutral
12/14/22 7:15 AM
NYSE, Nasdaq : JNJ, ABMD
Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022
Johnson& Johnson, the world’ s largest, most diversified healthcare products company, today announced that Athos Merger Sub, Inc., a wholly owned subsidiary of Johnson& Johnson, has extended the expiration date of its offer to acquire all of the outstanding shares of common stock of Abiomed, Inc., for an upfront payment of $380.00 per share in cash, plus one...
RHEA-AI
neutral
11/01/22 7:00 AM
Nasdaq, NYSE : ABMD, JNJ
Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*, up 7% on a Reported Basis Year Over Year
ABIOMED, Inc., a leader in breakthrough heart, lung and kidney support technologies, today announces financial results for the quarter ended September 30, 2022. The company saw an improvement in patient utilization in August and September as the impact from these headwinds moderated. U.S. product revenue of $208 million, an increase of 10% on a reported basis....
RHEA-AI
positive
10/31/22 8:02 AM
Nasdaq : ABMD
fda approval
Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure
Abiomed announces that Impella RP Flex with SmartAssist has received U.S. Food and Drug Administration pre-market approval, the FDA’ s highest level of approval, as safe and effective to treat acute right heart failure for up to 14 days. Impella RP Flex is implanted via the internal jugular vein, which enables patient mobility, and has dual-sensor technology...
RHEA-AI
neutral
10/24/22 12:00 PM
Nasdaq : ABMD
management
MedTechVets Appoints Patrice Sutherland, Enterprise Executive Director at Integra LifeScience, as New Board Chairperson
Patrice Sutherland, enterprise executive director at Integra Life Sciences, has been appointed Chairperson of the Board of Directors for MedTechVets, a nonprofit organization that helps military Veterans transition and gain employment at Medical Technology and Life Science companies. A U.S. Army combat Veteran, Sutherland succeeds Derek Herrera and...
RHEA-AI
very positive
10/20/22 10:24 AM
Nasdaq : ABMD
Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure
Abiomed announces the U.S. Food and Drug Administration has accepted and closed the post-approval study reports related to the pre-market approvals for Impella heart pumps. In total, Abiomed completed five post-approval studies for Impella over the seven years since its initial PMA was received. The totality of Impella data collected in the U.S., Europe and...
RHEA-AI
positive